---
figid: PMC9023153__ECAM2022-8489699.002
pmcid: PMC9023153
image_filename: ECAM2022-8489699.002.jpg
figure_link: /pmc/articles/PMC9023153/figure/fig2/
number: Figure 2
figure_title: ''
caption: (a) EL of mice in all groups. (b) TSPQ of mice in all groups. (c) TCP of
  mice in all groups. (d) Trajectory of the times crossing the platform in all groups.
  (e) Serum IS concentration of mice in all groups (Δp < 0.01, comparable to the S
  group; ∗∗p < 0.01, comparable to the M group; ∗p < 0.05, comparable to the M group;
  EL, escape latency; TSPQ, time spent in platform quadrant; TCP, times of crossing
  platform; S, sham operation group; M, model group; P, positive control group; MDFD-H,
  modified Dahuang Fuzi Decoction high-dose group; MDFD-M, modified Dahuang Fuzi Decoction
  medium-dose group; MDFD-L, modified Dahuang Fuzi Decoction low-dose group).
article_title: Treatment of Modified Dahuang Fuzi Decoction on Cognitive Impairment
  Induced by Chronic Kidney Disease through Regulating AhR/NF-κB/JNK Signal Pathway.
citation: Mingjia Gu, et al. Evid Based Complement Alternat Med. 2022;2022:8489699.
year: '2022'

doi: 10.1155/2022/8489699
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
